Evidence map›Paper›PMID 36670104›Full record

ArticleTranslational psychiatry2023

Fecal microbiota transplantation improves VPA-induced ASD mice by modulating the serotonergic and glutamatergic synapse signaling pathways.

Jifeng Wang, Yuan Cao, Weiliang Hou, Dexi Bi, Fang Yin, Yaohui Gao, Dengfeng Huang, Yingying Li, Zhan Cao, Yinmei Yan and 10 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Observational
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Jifeng Wang *Department of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Yuan Cao *Department of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Weiliang Hou *Intestinal Microenvironment Treatment Center, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Dexi BiDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Fang YinIntestinal Microenvironment Treatment Center, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Yaohui GaoDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Dengfeng HuangDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Yingying LiDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Zhan CaoIntestinal Microenvironment Treatment Center, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Yinmei YanDepartment of Pediatrics, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Jianhua ZhaoShanghai Majorbio Bio-pharm Technology Co.,Ltd, 201210, Shanghai, China.
Dewu KongShanghai Majorbio Bio-pharm Technology Co.,Ltd, 201210, Shanghai, China.
Xiaoqiong LvIntestinal Microenvironment Treatment Center, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Linsheng HuangDepartment of Pediatrics, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Hui ZhongDepartment of Pediatrics, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Chunyan WuIntestinal Microenvironment Treatment Center, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Qiyi ChenIntestinal Microenvironment Treatment Center, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China.
Rong YangDepartment of Pediatrics, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China. China.leexuechun1@126.com.
Qing WeiDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China. weiqing1971@126.com.ORCID 0000-0002-9007-5473
Huanlong QinIntestinal Microenvironment Treatment Center, Shanghai Tenth People's Hospital Affiliated to Tongji University, Department of Gastrointestinal Surgery, Shanghai Tenth People's Hospital Affiliated to Tongji University, 200072, Shanghai, China. huanlong_qin@live.cn.
Tongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a complex behavioral disorder diagnosed by social interaction difficulties, restricted verbal communication, and repetitive behaviors. Fecal microbiota transplantation (FMT) is a safe and efficient strategy to adjust gut microbiota dysbiosis and improve ASD-related behavioral symptoms, but its regulatory mechanism is unknown. The impact of the microbiota and its functions on ASD development is urgently being investigated to develop new therapeutic strategies for ASD. We reconstituted the gut microbiota of a valproic acid (VPA)-induced autism mouse model through FMT and found that ASD is in part driven by specific gut dysbiosis and metabolite changes that are involved in the signaling of serotonergic synapse and glutamatergic synapse pathways, which might be associated with behavioral changes. Further analysis of the microbiota showed a profound decrease in the genera Bacteroides and Odoribacter, both of which likely contributed to the regulation of serotonergic and glutamatergic synapse metabolism in mice. The engraftment of Turicibacter and Alistipes was also positively correlated with the improvement in behavior after FMT. Our results suggested that successful transfer of the gut microbiota from healthy donors to ASD mice was sufficient to improve ASD-related behaviors. Modulation of gut dysbiosis by FMT could be an effective approach to improve ASD-related behaviors in patients.

Indexed as

Autism Spectrum DisorderAnimalsDysbiosisFecal Microbiota TransplantationMiceSignal TransductionValproic AcidValproic Acid

Identifiers

PMID36670104
PMCPMC9859809
OpenAlexW4317582096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.